Clinical Trial Update: Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a trastuzumab-based CAR-T therapy targeting HER2-positive advanced breast cancer and other solid tumors, in Phase 1/2. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• Trastuzumab-based CAR-T cells

Snippet

Sponsor: National University Hospital, Singapore | Conditions: HER2+ Advanced Breast Cancer, Other Solid Tumors | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING